Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Flavia Di Nucci"'
Autor:
Nicholas S. Jones, Smita Kshirsagar, Vishnu Mohanan, Vidya Ramakrishnan, Flavia Di Nucci, Ling Ma, Jialin Mao, Hao Ding, Sha Klabunde, Domagoj Vucic, Lin Pan, Annemarie N. Lekkerkerker, Yuan Chen, Michael E. Rothenberg
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 10, Pp 1997-2009 (2023)
Abstract Receptor‐interacting protein 1 (RIP1) is a key regulator of multiple signaling pathways that mediate inflammatory responses and cell death. RIP1 kinase activity mediates apoptosis and necroptosis induced by tumor necrosis factor (TNF)‐α
Externí odkaz:
https://doaj.org/article/d142bcfea4d8440d95ab3f753b2b144b
Autor:
Zia Khan, Christian Hammer, Jonathan Carroll, Flavia Di Nucci, Sergio Ley Acosta, Vidya Maiya, Tushar Bhangale, Julie Hunkapiller, Ira Mellman, Matthew L. Albert, Mark I. McCarthy, G. Scott Chandler
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Endocrinopathies, such as thyroid autoimmunity, are common among patients treated with immune checkpoint inhibitors. Here, by using a polygenic risk score (PRS) derived from a hypothyroidism GWAS, the authors show that cancer patients with high PRS a
Externí odkaz:
https://doaj.org/article/c4d618dc88c448e799c4accf705c951a
Autor:
Franco Nolè, Iwona Skoneczna, Francesco Massari, Sabine de Ducla, Sjoukje F. Oosting, Robert Huddart, Herlinde Dumez, Ernest Choy, Pablo Maroto, Birute Brasiuniene, Daniel Castellano, Cora N. Sternberg, Yohann Loriot, Teresa Alonso Gordoa, Flavia Di Nucci, Andre P. Fay, Karina Vianna, Simon Fear
Publikováno v:
EUROPEAN JOURNAL OF CANCER
r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
European Journal of Cancer, 138, 202-211. ELSEVIER SCI LTD
r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
European Journal of Cancer, 138, 202-211. ELSEVIER SCI LTD
Aim: Patients with pre-existing autoimmune disease (AID) are typically excluded from clinical trials of immune checkpoint inhibitors, and there are limited data on outcomes in this population. The single-arm international SAUL study of atezolizumab e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ca329aacc3d0499c2cc1da1bda62b62
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1357
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1357
Autor:
Benton Brown, Steven M. Butler, Steven Francom, David S. Boyer, Flavia Di Nucci, Tsontcho Ianchulev, Roman G. Rubio, David F. Williams, Neil M. Bressler, Lisa Tuomi, Timothy Cramm
Publikováno v:
Retina (Philadelphia, Pa.). 32(9)
To analyze cerebrovascular accidents (CVAs) pooled from large, randomized, controlled clinical trials of ranibizumab treatment for neovascular age-related macular degeneration.Events in five trials (FOCUS, MARINA, ANCHOR, PIER, and SAILOR) were analy